Peter Heerma
Corporate Officer/Principal presso TRAVERE THERAPEUTICS, INC.
Patrimonio netto: 536 321 $ in data 30/04/2024
Profilo
Peter Heerma is currently the Chief Commercial Officer at Travere Therapeutics, Inc. Prior to this, he worked as the Director of Commercial Strategy Renal Care at Abbott Laboratories from 2003 to 2012, Senior Director of Portfolio Strategy at AbbVie, Inc. from 2012 to 2015, and General Manager of Oncology & Cardiovascular Products at Amgen, Inc. from 2015 to 2019.
He received his graduate degree from the University of Lund in 1997 and his undergraduate degree from Stenden University in 1996.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/02/2024 | 99 503 ( 0.13% ) | 536 321 $ | 30/04/2024 |
Posizioni attive di Peter Heerma
| Società | Posizione | Inizio |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2019 |
Precedenti posizioni note di Peter Heerma
| Società | Posizione | Fine |
|---|---|---|
| AMGEN INC. | Corporate Officer/Principal | 01/09/2019 |
| ABBVIE INC. | Corporate Officer/Principal | 01/11/2015 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01/11/2012 |
Formazione di Peter Heerma
| University of Lund | Graduate Degree |
| Stenden University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| ABBVIE INC. | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
- Borsa valori
- Insiders
- Peter Heerma
